1-2 of 2
Nancy B. Stamm
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antisense Inhibition of Survivin Expression as a Cancer Therapeutic

Rosa A. Carrasco, Nancy B. Stamm, Eric Marcusson, George Sandusky, Philip Iversen, Bharvin K.R. Patel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (2): 221–232.
https://doi.org/10.1158/1535-7163.MCT-10-0756
Published: 08 February 2011
View article titled, Antisense Inhibition of Survivin Expression as a Cancer Therapeutic
Open the PDF for Antisense Inhibition of Survivin Expression as a Cancer Therapeutic in another window
Includes: Supplementary data
Journal Articles

The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines

Chafiq Hamdouchi, Heather Keyser, Elizabeth Collins, Carlos Jaramillo, Jose Eugenio De Diego, Charles D. Spencer, Jack Alan Dempsey, Bryan D. Anderson, Tillie Leggett, Nancy B. Stamm, Richard M. Schultz, Scott A. Watkins, Kim Cocke, Stephanie Lemke, Teresa F. Burke, Richard P. Beckmann, Jeffrey T. Dixon, Thomas M. Gurganus, Nancy B. Rankl, Keith A. Houck, Faming Zhang, Michal Vieth, Juan Espinosa, David E. Timm, Robert M. Campbell, Bharvin K. R. Patel, Harold B. Brooks
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (1): 1–9.
https://doi.org/10.1158/1535-7163.1.3.1
Published: 28 January 2004
View article titled, The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-<em>a</em>]pyridines
Open the PDF for The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-<em>a</em>]pyridines in another window